Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"Randomized, Double-blind Clinical Trial to Assess the Efficacy of Tranexamic Acid in Reducing Blood Loss in Patients With Hip Fracture"

NCT05489185 is registered in ClinicalTrials.gov with Biogipuzkoa Health Research Institute as lead sponsor.

NCT NCT05489185
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05489185 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"Randomized, Double-blind Clinical Trial to Assess the Efficacy of Tranexamic Acid in Reducing Blood Loss in Patients With Hip Fracture"
Lead sponsor
Biogipuzkoa Health Research Institute
Phase
Phase 4
Overall status
Unknown status
Start date
May 30, 2023
Completion date
June 1, 2025
Enrollment
644 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hip fractures